Personalized brain imaging may significantly enhance the effectiveness of magnetic stimulation for individuals struggling with severe depression, according to findings from a new study. Researchers suggest that using detailed brain scans could improve targeting accuracy for this established treatment method.
The study, published June 24 in JAMA Psychiatry, indicates that such imaging helped direct accelerated transcranial magnetic stimulation (aTMS), leading to a noticeable reduction in depression symptoms and better patient response rates.
Improved Targeting for Depression Therapy
Dr. Joseph Taylor, an endowed chair in psychiatry at Mass General Brigham in Boston and the lead researcher, commented on the findings. He said the results “provide prospective evidence that there may be clinical advantages to using functional imaging to guide accelerated TMS treatment.”
Transcranial magnetic stimulation (TMS) is becoming more widely available. The technique uses magnetic pulses applied to the outside of a person’s skull to adjust brain activity. The U.S. Food and Drug Administration (FDA) approved TMS for treating major depressive disorder in adults back in 2008.
Related: What are the Common Types of Laboratory Incubators?
However, the way this treatment has been targeted traditionally relies on scalp-based measurements. Such measurements do not account for the unique structural differences in each individual’s brain, a point they have often raised.
The new investigation explored whether aTMS could be more effective against depression if guided by MRI scans. Dr. Taylor noted that while “Neuroimaging has taught us a tremendous amount about the brain,” it has been difficult to show that imaging can directly improve patient care.
For this investigation, the team recruited 40 people between 22 and 80 years old. All participants had major depressive disorder that had not responded to standard medication.
Patients were randomly assigned to one of two groups. One group received accelerated TMS using traditional scalp measurements for targeting. The other group had their treatment directed using the more precise MRI scans.
After one month, the group that received MRI-targeted treatment showed significantly lower symptoms of depression compared to those who received the usual TMS approach.
Related: Speed Dating Events in Australia A reliable way to meet single people
The outcomes showed a clear difference.
The MRI-guided group also demonstrated higher response rates to the treatment, with 80% showing improvement compared to 60% in the control group, the team reported.
Despite these promising results, they cautioned that a larger trial is needed to fully confirm these findings. Dr. Taylor explained that addressing this knowledge gap is important because adding imaging to TMS treatment introduces both cost and complexity, which needs careful consideration. The investigation’s aim was to measure the impact of their imaging-based targeting approach over and above conventional scalp-based methods.
These findings could influence how decisions are made regarding the wider implementation of accelerated TMS for patients with depression and other psychiatric conditions.